These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 29970967)
1. The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis. Zhang L; Wu B; Zha Z; Zhao H; Feng Y Cancer Manag Res; 2018; 10():1687-1703. PubMed ID: 29970967 [TBL] [Abstract][Full Text] [Related]
2. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis. Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of prognostic nutritional index on renal cell carcinoma: A meta-analysis of 7,629 patients. Peng Q; Liu L; Li T; Lei C; Wan H PLoS One; 2022; 17(3):e0265119. PubMed ID: 35312690 [TBL] [Abstract][Full Text] [Related]
4. The prevalence and prognostic and clinicopathological value of PD-L1 and PD-L2 in renal cell carcinoma patients: a systematic review and meta-analysis involving 3,389 patients. Lu Y; Song Y; Xu Y; Ou N; Liang Z; Hu R; Zhang W; Kang J; Wang X; Liu L; Yang Y; Liu X Transl Androl Urol; 2020 Apr; 9(2):367-381. PubMed ID: 32420142 [TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis. Wang Z; Peng S; Jiang N; Wang A; Liu S; Xie H; Guo L; Cai Q; Niu Y Oncotarget; 2017 Nov; 8(60):102361-102370. PubMed ID: 29254251 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Sarcomatoid Differentiation in Patients With Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Zhi H; Feng M; Liu S; Na T; Zhang N; BiLiGe W Front Oncol; 2020; 10():591001. PubMed ID: 33134181 [TBL] [Abstract][Full Text] [Related]
7. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis. Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026 [TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals. Wang Z; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y Cancer Manag Res; 2017; 9():679-689. PubMed ID: 29200888 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis. Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma. Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555 [TBL] [Abstract][Full Text] [Related]
12. The Clinicopathological Risk Factors in Renal Cell Cancer for the Oncological Outcomes Following Nephron-Sparing Surgery: A PRISMA Systematic Review and Meta-Analysis. Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J Front Oncol; 2020; 10():286. PubMed ID: 32211325 [No Abstract] [Full Text] [Related]
13. Unclassified renal cell carcinoma: a report of 56 cases. Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma. Wang Z; Peng S; Guo L; Xie H; Wang A; Shang Z; Niu Y Clin Chim Acta; 2018 Nov; 486():9-17. PubMed ID: 30006290 [TBL] [Abstract][Full Text] [Related]
15. Sarcomatoid renal cell carcinoma: MRI features and their association with survival. Cheng M; Duzgol C; Kim TH; Ghafoor S; Becker AS; Causa Andrieu PI; Gangai N; Jiang H; Hakimi AA; Vargas HA; Woo S Cancer Imaging; 2023 Feb; 23(1):16. PubMed ID: 36793052 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis. Jin M; Yuan S; Yuan Y; Yi L Front Oncol; 2021; 11():735803. PubMed ID: 34950577 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis. Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of albumin-to-globulin ratio in patients with renal cell carcinoma: a meta-analysis. Mao H; Yang F Front Oncol; 2023; 13():1210451. PubMed ID: 37538115 [TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Lymphovascular Invasion in Patients With Upper Tract Urinary Carcinoma After Surgery: An Updated Systematic Review and Meta-Analysis. Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Feng Y Front Oncol; 2020; 10():487. PubMed ID: 32391257 [No Abstract] [Full Text] [Related]
20. Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis. Xie Y; Chen L; Ma X; Li H; Gu L; Gao Y; Fan Y; Zhang Y; Zhang X Sci Rep; 2017 Mar; 7():44281. PubMed ID: 28287186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]